Cargando…

Medical management of heavy menstrual bleeding

Women with benign heavy menstrual bleeding have the choice of a number of medical treatment options to reduce their blood loss and improve quality of life. The role of the clinician is to provide information to facilitate women in making an appropriate choice. Unfortunately, many options can be asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Maybin, Jacqueline A, Critchley, Hilary OD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728737/
https://www.ncbi.nlm.nih.gov/pubmed/26695687
http://dx.doi.org/10.2217/whe.15.100
_version_ 1782412168662089728
author Maybin, Jacqueline A
Critchley, Hilary OD
author_facet Maybin, Jacqueline A
Critchley, Hilary OD
author_sort Maybin, Jacqueline A
collection PubMed
description Women with benign heavy menstrual bleeding have the choice of a number of medical treatment options to reduce their blood loss and improve quality of life. The role of the clinician is to provide information to facilitate women in making an appropriate choice. Unfortunately, many options can be associated with hormonal side effects, prevention of fertility and lack of efficacy, leading to discontinuation and progression to surgical interventions. Herein, we discuss the various options currently available to women, including antifibrinolytics, nonsteroidal anti-inflammatory preparations, oral contraceptive pills and oral, injectable and intrauterine progestogens. In addition, we describe the more novel option of selective progesterone receptor modulators and their current benefits and limitations.
format Online
Article
Text
id pubmed-4728737
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-47287372016-01-27 Medical management of heavy menstrual bleeding Maybin, Jacqueline A Critchley, Hilary OD Womens Health (Lond) Special Report Women with benign heavy menstrual bleeding have the choice of a number of medical treatment options to reduce their blood loss and improve quality of life. The role of the clinician is to provide information to facilitate women in making an appropriate choice. Unfortunately, many options can be associated with hormonal side effects, prevention of fertility and lack of efficacy, leading to discontinuation and progression to surgical interventions. Herein, we discuss the various options currently available to women, including antifibrinolytics, nonsteroidal anti-inflammatory preparations, oral contraceptive pills and oral, injectable and intrauterine progestogens. In addition, we describe the more novel option of selective progesterone receptor modulators and their current benefits and limitations. Future Medicine Ltd 2016-01 /pmc/articles/PMC4728737/ /pubmed/26695687 http://dx.doi.org/10.2217/whe.15.100 Text en © Hilary OD Critchley This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Special Report
Maybin, Jacqueline A
Critchley, Hilary OD
Medical management of heavy menstrual bleeding
title Medical management of heavy menstrual bleeding
title_full Medical management of heavy menstrual bleeding
title_fullStr Medical management of heavy menstrual bleeding
title_full_unstemmed Medical management of heavy menstrual bleeding
title_short Medical management of heavy menstrual bleeding
title_sort medical management of heavy menstrual bleeding
topic Special Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728737/
https://www.ncbi.nlm.nih.gov/pubmed/26695687
http://dx.doi.org/10.2217/whe.15.100
work_keys_str_mv AT maybinjacquelinea medicalmanagementofheavymenstrualbleeding
AT critchleyhilaryod medicalmanagementofheavymenstrualbleeding